Related Experiment Video

Updated: Jun 22, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Anti-angiogenic agents and cancer: current insights and future perspectives

Boel De Paepe1

  • 1Ghent University Hospital, Neurology and Pathology, UZ 1K12A, De Pintelaan 185, 9000 Ghent, Belgium. boel.depaepe@ugent.be

Recent Patents on Anti-Cancer Drug Discovery
|June 13, 2009
PubMed

Insights

Tumors need new blood vessels to grow. Anti-angiogenic therapies target tumor blood supply, potentially slowing cancer growth and metastasis.

Area of Science:

  • Oncology
  • Vascular Biology
  • Pharmacology

Background:

  • Tumor growth necessitates neovascularization to supply oxygen and nutrients.
  • Cancer cells secrete factors that promote new blood vessel formation around tumors.
  • Targeting tumor angiogenesis is a strategy to inhibit cancer progression.

Purpose of the Study:

  • To review novel anti-angiogenic agents for cancer therapy.
  • To discuss therapeutic strategies targeting tumor vascularization.
  • To explore the potential of these agents as adjunct cancer treatments.

Main Methods:

  • Review of scientific literature on anti-angiogenic agents.
  • Analysis of novel therapeutic compounds and natural metabolites.
  • Discussion of relevant patents in the field.

Main Results:

  • Identification of diverse anti-angiogenic agents, including antibodies, pharmaceuticals, and natural products.
  • Overview of agents targeting vascular growth factors and angiotensin II.
  • Examination of patented anti-angiogenic therapies.

Conclusions:

  • Novel anti-angiogenic agents show promise for cancer treatment.
  • These agents could complement existing chemotherapy and radiation therapy.
  • Further development may lead to valuable new anti-cancer therapeutics.

More Related Videos

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research08:53

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...